Insights and Stories of Nichola Saminather

Sep. 30, 2019 at 1:19 pm CDT

Toronto | Reuters — A U.S. recommendation that consumers avoid vaping products containing the active ingredient in marijuana ahead of their legalization in Canada next month could be a blow to Canadian cannabis companies’ hopes that the higher-margin products will help propel them to profitability. The U.S. Centers for Disease […]

By Nichola Saminather

Dec. 19, 2018 at 4:44 pm CST

Toronto | Reuters — Anheuser-Busch InBev, the world’s largest brewer, and Canadian pot producer Tilray Inc. are partnering in a US$100 million joint venture to research cannabis-infused non-alcoholic drinks for the Canadian market, the companies said Wednesday. The alliance, the latest in a string of deals by global alcohol and […]

By Nichola Saminather, susan-taylor

Oct. 24, 2018 at 4:10 pm CDT

Toronto | Reuters – U.S. cannabis retailer Curaleaf Holdings Inc is raising about $400 million, almost three times its original target, in Toronto, in a deal that would value the company at close to $4 billion, people familiar with the situation told Reuters. The move by the Wakefield, Massachusetts-based company, […]

By John Tilak, Nichola Saminather

Oct. 18, 2018 at 5:31 am CDT

Toronto/Vancouver | Reuters — Canada became the first industrialized nation to legalize recreational cannabis on Wednesday, but a lawful buzz will be hard to come by in its biggest cities like Toronto and Vancouver, where stores are not yet open. The day was historic for the country as Canadian adults […]

By Julie Gordon, Nichola Saminather

Sep. 17, 2018 at 2:56 am CDT

Toronto/London | Reuters — A favorite of DIY stock pickers, Canadian cannabis firms are trying to bolster their institutional investor base by ramping up efforts to woo European funds as countries across the region approve marijuana for medical use. For some time companies including Canopy Growth, Aurora Cannabis and Tilray […]

By Nichola Saminather, Simon Jessop